Efficacy and safety of SGLT2 inhibitor, Ipragliflozin in type 2 diabetes patients.
Latest Information Update: 03 Jul 2014
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms ESST2
- 03 Jul 2014 New trial record